返回 Agenda
Clinical Trial Diversity: Moving from Admiring the Problem to Solving it
Session Chair(s)
Jane Myles, MSC
Program Director
Jemtech Co, United States
This forum will take discussions about clinical trial diversity to the next level, focusing on practical solutions and strategies for strengthening diversity in clinical trials. A panel of multi-stakeholder experts will provide their perspectives.
Learning Objective : Describe strategies for increasing diversity in clinical trial research; Discuss examples of innovations in enrollment and recruitment of diverse patients as well as challenges overcome.
Speaker(s)
Inclusive Trial Participation: Imperative or Nice to Have?
Jane Myles, MSC
Jemtech Co, United States
Program Director
FDA Perspective
Richardae Araojo, PHARMD, MS
FDA, United States
Associate Commissioner for Minority Health, Director, Office of Minority Health
Panelist
Fabian Sandoval, MD
ECRI, United States
President and Chief Executive Officer
Panelist
Madeline Geday
Astellas, United States
Senior Director, DCT Office/COE Patient Centriity
Patient Perspective
Mindy Leffler
Casimir, United States
Rare Disease Parent; Partner